New Treatment in Australia: A New Hope for Obesity Management ?
Australia is currently observing the arrival of retatrutide, a cutting-edge dual GIP and GLP-1 receptor therapy, representing a exciting advance in obesity treatment . Early study data have demonstrated impressive results, showing greater efficacy than existing treatments like semaglutide. While